Press Release – raising seed funds
ALTERDIAG raised €2M in Seed funding to develop innovative Rapid Diagnostic Tests Paris, France, January 29, 2025 – ALTERDIAG, a private biotech company specializing in the development of rapid diagnostic tests targeting infectious disease pathogens, announces a €2 million seed funding round from Forepont Capital Partners, a New York-based venture capital firm specializing in healthcare […]
Press Release – raising seed funds Read More »
